why choose us

First received: June 08, 2023

Clinical Trial: Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Ulcerative Colitis

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate the Efficacy and Safety of CU104 in Patients With Moderate to Severe Ulcerative Colitis

Brief Summary: The study is designed to investigate efficacy and safety of CU104 in patients with moderate to severe ulcerative colitis.

Read more